Found: 59
Select item for more details and to access through your institution.
Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 12, p. 3611, doi. 10.3390/jcm13123611
- By:
- Publication type:
- Article
Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 5573, doi. 10.3390/ijms25115573
- By:
- Publication type:
- Article
Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1440, doi. 10.3390/cancers16071440
- By:
- Publication type:
- Article
Risk of cardiovascular toxicity with combination of immune-checkpoint inhibitors and angiogenesis inhibitors: a meta-analysis.
- Published in:
- Frontiers in Cardiovascular Medicine, 2024, p. 1, doi. 10.3389/fcvm.2024.1309100
- By:
- Publication type:
- Article
A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359231217958
- By:
- Publication type:
- Article
Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2345185, doi. 10.1001/jamanetworkopen.2023.45185
- By:
- Publication type:
- Article
Integrating extracellular vesicle and circulating cell‐free DNA analysis using a single plasma aliquot improves the detection of HER2 positivity in breast cancer patients.
- Published in:
- Journal of Extracellular Biology, 2023, v. 2, n. 9, p. 1, doi. 10.1002/jex2.108
- By:
- Publication type:
- Article
Impact of KRAS Mutations on Clinical Outcomes of Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer Receiving Anti-PD-1/PD-L1 Therapy.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 1, p. 129, doi. 10.1007/s11523-022-00934-6
- By:
- Publication type:
- Article
The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study.
- Published in:
- Therapeutic Advances in Urology, 2023, v. 15, p. 1, doi. 10.1177/17562872231187216
- By:
- Publication type:
- Article
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network.
- Published in:
- Oncologist, 2022, v. 27, n. 12, p. e949, doi. 10.1093/oncolo/oyac147
- By:
- Publication type:
- Article
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO Network.
- Published in:
- Current Oncology, 2022, v. 29, n. 10, p. 7745, doi. 10.3390/curroncol29100612
- By:
- Publication type:
- Article
Apalutamide, Darolutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): A Critical Review.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1792, doi. 10.3390/cancers14071792
- By:
- Publication type:
- Article
A Model-Based Framework to Identify Optimal Administration Protocols for Immunotherapies in Castration-Resistance Prostate Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 135, doi. 10.3390/cancers14010135
- By:
- Publication type:
- Article
A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training-Validation Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 5, p. 625, doi. 10.1007/s11523-021-00828-z
- By:
- Publication type:
- Article
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study).
- Published in:
- Clinical Medicine Insights: Oncology, 2021, p. 1, doi. 10.1177/11795549211021667
- By:
- Publication type:
- Article
Management of Breast Cancer Patients during the COVID-19 Pandemic in Northern Italy.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Learning from organisational changes in the management of breast cancer patients during the COVID-19 pandemic: Preparing for a second wave at a breast unit in northern Italy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and safety of PD1/PDL1 blockade with platinum-based chemotherapy for extensive small cell lung cancer: A pooled analysis of randomized trials.
- Published in:
- European Journal of Clinical Investigation, 2021, v. 51, n. 5, p. 1, doi. 10.1111/eci.13483
- By:
- Publication type:
- Article
An Italian, multicenter, real-world, retrospective study of first-line pazopanib in unselected metastatic renal-cell carcinoma patients: the 'Pamerit' study.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 3, p. 484, doi. 10.1093/jjco/hyaa193
- By:
- Publication type:
- Article
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study).
- Published in:
- Clinical Medicine Insights: Oncology, 2021, v. 15, p. 1, doi. 10.1177/11795549211021667
- By:
- Publication type:
- Article
GU-CA-COVID: a clinical audit among Italian genitourinary oncologists during the first COVID-19 outbreak.
- Published in:
- Therapeutic Advances in Urology, 2021, v. 13, p. 1, doi. 10.1177/17562872211054302
- By:
- Publication type:
- Article
Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysis.
- Published in:
- Therapeutic Advances in Urology, 2021, v. 13, p. 1, doi. 10.1177/17562872211053189
- By:
- Publication type:
- Article
Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 11, p. 2633, doi. 10.1007/s00259-020-04796-w
- By:
- Publication type:
- Article
BRCA Mutations in Prostate Cancer: Prognostic and Predictive Implications.
- Published in:
- Journal of Oncology, 2020, p. 1, doi. 10.1155/2020/4986365
- By:
- Publication type:
- Article
Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 1950, doi. 10.3390/jcm9061950
- By:
- Publication type:
- Article
Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1131, doi. 10.3390/cancers12051131
- By:
- Publication type:
- Article
Monitoring Patients with Metastatic Hormone-Sensitive and Metastatic Castration-Resistant Prostate Cancer: A Multidisciplinary Consensus Document.
- Published in:
- Cancers, 2019, v. 11, n. 12, p. 1908, doi. 10.3390/cancers11121908
- By:
- Publication type:
- Article
Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone.
- Published in:
- Prostate, 2017, v. 77, n. 9, p. 1012, doi. 10.1002/pros.23357
- By:
- Publication type:
- Article
Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone.
- Published in:
- Frontiers in Pharmacology, 2016, v. 7, p. 1, doi. 10.3389/fphar.2016.00376
- By:
- Publication type:
- Article
Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer.
- Published in:
- PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0158952
- By:
- Publication type:
- Article
Association Between Early PSA Increase and Clinical Outcome in Patients Treated with Enzalutamide for Metastatic Castration Resistant Prostate Cancer.
- Published in:
- Molecular Diagnosis & Therapy, 2016, v. 20, n. 3, p. 255, doi. 10.1007/s40291-016-0196-1
- By:
- Publication type:
- Article
Very Early PSA Response to Abiraterone in mCRPC Patients: A Novel Prognostic Factor Predicting Overall Survival.
- Published in:
- Frontiers in Pharmacology, 2016, p. 1, doi. 10.3389/fphar.2016.00123
- By:
- Publication type:
- Article
Splice variants of androgen receptor and prostate cancer.
- Published in:
- Oncology Reviews, 2016, v. 10, n. 1, p. 14, doi. 10.4081/oncol.2016.297
- By:
- Publication type:
- Article
Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone.
- Published in:
- Prostate, 2015, v. 75, n. 12, p. 1329, doi. 10.1002/pros.23014
- By:
- Publication type:
- Article
Androgen deprivation therapy in castrate-resistant prostate cancer: how important is GnRH agonist backbone therapy?
- Published in:
- World Journal of Urology, 2015, v. 33, n. 8, p. 1079, doi. 10.1007/s00345-014-1406-2
- By:
- Publication type:
- Article
Impact of post-implant dosimetric parameters on the quality of life of patients treated with low-dose rate brachytherapy for localised prostate cancer: results of a single-institution study.
- Published in:
- Radiation Oncology, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13014-015-0434-4
- By:
- Publication type:
- Article
Docetaxel rechallenge after an initial good response in patients with metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2015, v. 115, n. 5, p. 744, doi. 10.1111/bju.12845
- By:
- Publication type:
- Article
Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme.
- Published in:
- BJU International, 2015, v. 115, n. 5, p. 764, doi. 10.1111/bju.12857
- By:
- Publication type:
- Article
Impact of post-implant dosimetric parameters on the quality of life of patients treated with low-dose rate brachytherapy for localised prostate cancer: results of a single-institution study.
- Published in:
- Radiation Oncology, 2015, v. 10, n. 1, p. 130, doi. 10.1186/s13014-015-0434-4
- By:
- Publication type:
- Article
Frequency of brain metastases from prostate cancer: an 18-year single-institution experience.
- Published in:
- Journal of Neuro-Oncology, 2013, v. 111, n. 2, p. 163, doi. 10.1007/s11060-012-0994-1
- By:
- Publication type:
- Article
Central nervous system metastases from castration-resistant prostate cancer in the docetaxel era.
- Published in:
- Journal of Neuro-Oncology, 2012, v. 107, n. 1, p. 191, doi. 10.1007/s11060-011-0734-y
- By:
- Publication type:
- Article
Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study.
- Published in:
- Radiation Oncology, 2012, v. 7, n. 1, p. 1, doi. 10.1186/1748-717X-7-177
- By:
- Publication type:
- Article
A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 369, doi. 10.1007/s00280-011-1710-0
- By:
- Publication type:
- Article
Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Impact of docetaxel-based chemotherapy on quality of life of patients with castration-resistant prostate cancer: results from a prospective phase II randomized trial.
- Published in:
- BJU International, 2011, v. 108, n. 11, p. 1825, doi. 10.1111/j.1464-410X.2011.10277.x
- By:
- Publication type:
- Article
Gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 6, p. 1190, doi. 10.1002/cncr.25667
- By:
- Publication type:
- Article
Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 6, p. 1197, doi. 10.1007/s00280-010-1255-7
- By:
- Publication type:
- Article
Docetaxel, with or without estramustine phosphate, as first-line chemotherapy for hormone-refractory prostate cancer: results of a multicentre, randomized phase II trial.
- Published in:
- BJU International, 2008, v. 102, n. 9, p. 1080, doi. 10.1111/j.1464-410X.2008.07779.x
- By:
- Publication type:
- Article